Home › Funds › MONTANOVA CAPITAL, LLC › ZURA
MONTANOVA CAPITAL, LLC position in ZURA
ZURA BIO · Health Care
MONTANOVA CAPITAL, LLC reported holding 9,443,001 shares of ZURA (ZURA BIO) in its Q2 2026 13F filing — a position valued at US$55.7M, representing 1.02% of its reported portfolio and ranking #28 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed ZURA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MONTANOVA CAPITAL, LLC's ZURA position evolved
MONTANOVA CAPITAL, LLC first disclosed a stake in ZURA in Q3 2023 at 2,850,000 shares (US$18.8M). The position peaked in Q2 2026 at 9,443,001 shares, worth US$55.7M. Across 12 filings, MONTANOVA CAPITAL, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 9,443,001 shares valued at US$55.7M — an increase of 376,000 shares quarter over quarter.. Notable position changes include a 71% increase in Q2 2024 (shares rose 16% over the following quarter), a 63% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.85M | $18.81M | New |
| Q4 2023 | 2.85M | $13.31M | Hold |
| Q1 2024 | 2.85M | $7.32M | Hold |
| Q2 2024 | 4.86M | $17.01M | Add |
| Q3 2024 | 4.86M | $19.74M | Hold |
| Q4 2024 | 4.86M | $12.15M | Hold |
| Q1 2025 | 4.86M | $6.27M | Hold |
| Q2 2025 | 4.86M | $5.10M | Hold |
| Q3 2025 | 5.47M | $23.70M | Add |
| Q4 2025 | 5.57M | $29.17M | Add |
| Q1 2026 | 9.07M | $53.95M | Add |
| Q2 2026 | 9.44M | $55.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (ZURA BIO) is a Health Care company. 52 other funds we track also report a position in ZURA — the largest reported positions include Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M), GREAT POINT PARTNERS LLC (US$24.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- Venrock Adviser, LLC 6.43M sh · $37.97M · Q2 2026
- MPM BioImpact LLC 4.47M sh · $26.39M · Q2 2026
- GREAT POINT PARTNERS LLC 4.22M sh · $24.87M · Q2 2026
- BRAIDWELL LP 3.98M sh · $23.48M · Q2 2026
- Commodore Capital LP 3.25M sh · $19.18M · Q2 2026
- Saturn V Capital Management LP 2.10M sh · $12.40M · Q2 2026
- QVT Financial LP 1.90M sh · $11.18M · Q2 2026
- ADAR1 Capital Management, LLC 1.76M sh · $10.38M · Q2 2026
- STEMPOINT CAPITAL LP 1.37M sh · $8.07M · Q2 2026
- Ikarian Capital, LLC 1.22M sh · $7.19M · Q2 2026
- EcoR1 Capital, LLC 1.18M sh · $6.96M · Q2 2026
- Boxer Capital Management, LLC 900.00K sh · $5.31M · Q2 2026
More on MONTANOVA CAPITAL, LLC
FAQ
How long has MONTANOVA CAPITAL, LLC held ZURA?
MONTANOVA CAPITAL, LLC has disclosed ZURA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is MONTANOVA CAPITAL, LLC's current position in ZURA?
As of Q2 2026, MONTANOVA CAPITAL, LLC holds 9.44M shares of ZURA (ZURA BIO), valued at $55.71M, representing 1.02% of its reported portfolio and ranking #28.
Has MONTANOVA CAPITAL, LLC been buying or selling ZURA?
In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC increased its position in ZURA. The position peaked in Q2 2026 at 9.44M shares.
Which other funds hold ZURA?
Other major institutional holders of ZURA include Venrock Adviser, LLC, MPM BioImpact LLC, GREAT POINT PARTNERS LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.